The shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) went down during the trading session by -$0.59 on Wednesday, trading at $5.41. At the moment, the company has a debt-to-equity ratio of 0.94, a current ratio of 7.90 , and a quick ratio of 7.80 . The stock has a 52-week low of $4.34 while its 52-weeks high is $7.66. The total market cap for the stock is $1.24B its price-to-earnings-growth ratio reads 77.01 while it has a beta of 1.12.
TXMD has flown up as the subject of gossips for a number of analysts. Analysts at JP Morgan Initiated the shares of TherapeuticsMD, Inc to Overweight when they released a research note on June 15th, 2018. Morgan Stanley analysts Initiated the shares of TherapeuticsMD, Inc. to Equal-Weight in a research note they presented on September 8th, 2017, but they now have set a price target of $6. Analysts at Oppenheimer Upgrade the shares of TherapeuticsMD, Inc. from Perform to Outperform when they released a research note on July 11th, 2017, but they now have set a price target of $47, which is an increase from the previous $45.
The current market cap of Tiffany & Co. is valued at $13.37B. The value there would make it reasonable for the investors to decide the dimensions of Tiffany & Co. not at all like the standard sales or statistics of their aggregate resources.
Taking a look at the current stock price for Tiffany & Co. (NYSE:TIF), we could notice that the shares are trading close to the $122.95 level. Financial specialists have a propensity for following stock value levels in connection to their 52-week high and low levels. The 52-week high of the stock is currently $141.64 while its 52-weeks low stands at $90.46.
The performance of Tiffany & Co. (NYSE:TIF), so far this year is at +6.43%. The performance of the stock over the past seven days has dropped by -11.31%, over the past one-month price index is -10.53% while over the last three months is -17.08%. Its six months performance has been +13.19% while for the past 52 weeks is +6.19%.
Notwithstanding that, the passion for the stock has increased, which sees an increase in its trading volume by 156.714% above its longer-run average levels. This information shouldn’t be overlooked due to the greatly float size in the stock of 119.45M shares.
Trading at the moment with a market cap of $13.37B, TIF has a significant cash 752.8 million on their books, which will have to be weighed and compared to their $610.3 million in total current liabilities. TIF is raking in trailing 12 months revenue which is around 1.08 billion. Notwithstanding that, the firm is seeing a foremost top-line progress, with their year-over-year quarterly revenue increasing by 12.10%.